Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Nuvation Bio (NUVB) Net Margin (2024 - 2025)

Nuvation Bio (NUVB) has disclosed Net Margin for 2 consecutive years, with 87.4% as the latest value for Q4 2025.

  • On a quarterly basis, Net Margin rose 77838.0% to 87.4% in Q4 2025 year-over-year; TTM through Dec 2025 was 325.31%, a 688845.0% increase, with the full-year FY2025 number at 325.31%, up 688845.0% from a year prior.
  • Net Margin was 87.4% for Q4 2025 at Nuvation Bio, up from 425.24% in the prior quarter.
  • In the past five years, Net Margin ranged from a high of 87.4% in Q4 2025 to a low of 32229.41% in Q2 2024.